Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 478-670-2 | CAS number: 139306-10-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- repeated dose toxicity: oral
- Adequacy of study:
- other information
Data source
Reference
- Reference Type:
- other: Body responsible for the test
- Title:
- Unnamed
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Principles of method if other than guideline:
- - European Community (EC) Council Directive 96/54/EC, Annex
IV.D, replacing EC Directive 67/548/EEC, Part B : Methods
for the Determination of Toxicity and other Health Effects;
B.7: "Repeated Dose (28 days) Toxicity (oral)". Official
Journal of the European Communities No. L248, September
1996.
- Organisation for Economic Co-operation and Development
(OECD), OECD Guidelines for Testing of Chemicals, Section 4,
Health Effects, No. 407: "Repeated Dose 28-day Oral
Toxicity Study in Rodents", Paris Cedex, 27 July 1995.
- United States Environmental Protection Agency (EPA).
Health Effects Test Guidelines, OPPTS 870.3050, Repeated
dose 28-day oral toxicity study in rodents. Office of
Prevention, Pesticides and Toxic Substances (7101), EPA 712-
C-00-366, July 2000. - GLP compliance:
- yes
- Limit test:
- no
Test animals
- Species:
- other: Rat: Crl:WI(Han)
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- propylene glycol
- Details on oral exposure:
- Method of administration:
gavage - Duration of treatment / exposure:
- Test duration: 28 days
- Frequency of treatment:
- Dosing regime: 7 days/week
- No. of animals per sex per dose:
- Male: 5 animals at 50 mg/kg bw/day
Male: 5 animals at 150 mg/kg bw/day
Male: 5 animals at 500 mg/kg bw/day
Female: 5 animals at 50 mg/kg bw/day
Female: 5 animals at 150 mg/kg bw/day
Female: 5 animals at 500 mg/kg bw/day
Results and discussion
Results of examinations
- Details on results:
- Clinical observations:
A total of four animals at 500 mg/kg/day did not survive
their scheduled treatment period. One male and one female at
500 mg/kg/day were found dead on days 15 and 4,
respectively. Another male and female at this dose level
were sacrificed in extremis on days 14 and 22, respectively.
Clinical signs noted among most animals at 500 mg/kg/day
that did not survive until their scheduled termination:
hunched posture, breathing difficulties, piloerection, a
lean appearance and ptosis. A hunched posture was also noted
among all surviving females at 500 mg/kg/day.
No clinical signs were noted among control animals, and
males at 50 mg/kg/day.
Laboratory findings:
Haematology:
No toxicologically relevant changes occurred in
haematological parameters of surviving rats.
Clinical biochemistry:
The following (statistically significant) changes in
clinical biochemistry parameters distinguished treated
animals from control animals:
- Increased ALAT in one male at 500 mg/kg/day, and in
females at 500 mg/kg/day,
- Increased ALP in females at 500 mg/kg/day and also in
three females at 150 mg/kg/day and 1 female at 50 mg/kg/day.
- Increased glucose levels in two males at 500 mg/kg/day,
and in females at 500 mg/kg/day,
- Increased cholesterol levels in females at 500 mg/kg/day
(not statistically significant, but showing a dose-related
trend)
- Reduced sodium levels in males at 150 and 500 mg/kg/day,
- Reduced chloride levels in males at 500 mg/kg/day, and in
one female at 500 mg/kg/day,
- Increased potassium levels in males at 150 and 500
mg/kg/day (not statistically significant at 500 mg/kg/day),
and in females at 500 mg/kg/day,
Effects in organs:
Macroscopic examination:
Findings among animals at 500 mg/kg/day that did not survive
until their scheduled termination consisted of an emaciated
appearance, a stage of beginning autolysis, a gastro-
intestinal tract distended with gas, red discolouration of
the lungs, enlargement of the liver, red foci on the thymus,
and fluid in the body cavity. No such findings were present
among the surviving animals at 500 mg/kg/day.
No macroscopic abnormalities were noted among control
animals, males at 50 mg/kg/day and males and females at 150
mg/kg/day.
Organ weights:
Spleen and thymus weight (absolute and relative weights) of
surviving females at 500 mg/kg/day were slightly reduced (no
level of statistical significance was achieved).
Microscopic examination:
There were no microscopic findings recorded which could be
attributed specifically to treatment with the test
substance. Thymic atrophy and in one case necrosis in the
animals dying or killed in extremis during the study was
considered to be indicative of general health status rather
than a specifc effect of the test substance.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg bw/day (nominal)
- Basis for effect level:
- other: original NCD unit is mg/kg/day.
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Classified as: Not classified
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
